These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27839805)

  • 21. Sources of hospital variation in short-term readmission rates after percutaneous coronary intervention.
    Yeh RW; Rosenfield K; Zelevinsky K; Mauri L; Sakhuja R; Shivapour DM; Lovett A; Weiner BH; Jacobs AK; Normand SL
    Circ Cardiovasc Interv; 2012 Apr; 5(2):227-36. PubMed ID: 22438431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Future of the PCI Readmission Metric.
    Wasfy JH; Yeh RW
    Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):186-9. PubMed ID: 26812931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Readmissions to Hospital After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Factors Associated with Readmissions.
    Kwok CS; Narain A; Pacha HM; Lo TS; Holroyd EW; Alraies MC; Nolan J; Mamas MA
    Cardiovasc Revasc Med; 2020 Mar; 21(3):375-391. PubMed ID: 31196797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of Length of Stay to Unplanned Readmissions for Patients Who Undergo Elective Percutaneous Coronary Intervention.
    Kwok CS; Rao SV; Gilchrist IC; Potts J; Nagaraja V; Gunning M; Nolan J; Kontopantelis E; Bertrand OF; Mamas MA
    Am J Cardiol; 2019 Jan; 123(1):33-43. PubMed ID: 30539746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation Between Age and Unplanned Readmissions After Percutaneous Coronary Intervention (Findings from the Nationwide Readmission Database).
    Kwok CS; Rao SV; Gilchrist I; Martinez SC; Al Ayoubi F; Potts J; Rashid M; Kontopantelis E; Myint PK; Mamas MA
    Am J Cardiol; 2018 Jul; 122(2):220-228. PubMed ID: 29861049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Interventions to Reduce Preventable Hospital Readmission After Percutaneous Coronary Intervention.
    Tanguturi VK; Temin E; Yeh RW; Thompson RW; Rao SK; Mallick A; Cavallo E; Ferris TG; Wasfy JH
    Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):600-4. PubMed ID: 27553598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and predictors of 30-day hospital readmission rate following percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry).
    Ricciardi MJ; Selzer F; Marroquin OC; Holper EM; Venkitachalam L; Williams DO; Kelsey SF; Laskey WK
    Am J Cardiol; 2012 Nov; 110(10):1389-96. PubMed ID: 22853982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous coronary intervention and 30-day unplanned readmission with chest pain in the United States (Nationwide Readmissions Database).
    Sykes R; Mohamed MO; Kwok CS; Mamas MA; Berry C
    Clin Cardiol; 2021 Mar; 44(3):291-306. PubMed ID: 33590937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Readmissions After Acute Myocardial Infarction.
    Kwok CS; Wong CW; Shufflebotham H; Brindley L; Fatima T; Shufflebotham A; Barker D; Pawala A; Heatlie G; Mamas MA
    Am J Cardiol; 2017 Sep; 120(5):723-728. PubMed ID: 28728745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: data from a large multi-centre Australian registry.
    Ariyaratne TV; Ademi Z; Duffy SJ; Andrianopoulos N; Billah B; Brennan AL; New G; Black A; Ajani AE; Clark DJ; Yan BP; Yap CH; Reid CM
    Int J Cardiol; 2013 Oct; 168(3):2783-90. PubMed ID: 23643437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact Of Cirrhosis On 90-Day Outcomes After Percutaneous Coronary Intervention (from A Nationwide Database).
    Lu DY; Steitieh D; Feldman DN; Cheung JW; Wong SC; Halazun H; Halazun KJ; Amin N; Wang J; Chae J; Wilensky RL; Kim LK
    Am J Cardiol; 2020 May; 125(9):1295-1304. PubMed ID: 32145896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends and predictors of rehospitalisation following an acute coronary syndrome: report from the Australian and New Zealand population of the Global Registry of Acute Coronary Events (GRACE).
    Sangu PV; Ranasinghe I; Aliprandi Costa B; Devlin G; Elliot J; Lefkovitz J; Brieger D
    Heart; 2012 Dec; 98(23):1728-31. PubMed ID: 23010286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sociodemographic, Clinical and Patient-Reported Outcomes and Readmission After Heart Valve Surgery.
    Borregaard B; Sørensen J; Ekholm O; Møller JE; Riber LP; Thrysoee L; Thorup CB; Vamosi M; Christensen AV; Rasmussen TB; Berg SK
    J Heart Valve Dis; 2018 Jan; 27(1):78-86. PubMed ID: 30560603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
    Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
    Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries.
    Yan BP; Clark DJ; Buxton B; Ajani AE; Smith JA; Duffy SJ; Shardey GC; Skillington PD; Farouque O; Yii M; Yap CH; Andrianopoulos N; Brennan A; Dinh D; Reid CM; ;
    Heart Lung Circ; 2009 Jun; 18(3):184-90. PubMed ID: 19268632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
    Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing the Prediction of 30-Day Readmission After Percutaneous Coronary Intervention Using Data Extracted by Querying of the Electronic Health Record.
    Wasfy JH; Singal G; O'Brien C; Blumenthal DM; Kennedy KF; Strom JB; Spertus JA; Mauri L; Normand SL; Yeh RW
    Circ Cardiovasc Qual Outcomes; 2015 Sep; 8(5):477-85. PubMed ID: 26286871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of diabetes on long-term all-cause re-hospitalization after revascularization with percutaneous coronary intervention.
    Hansen KN; Noori M; Christiansen EH; Kristiansen EB; Maeng M; Zwisler ADO; Borregaard B; Søgaard R; Veien KT; Junker A; Jensen LO
    Diab Vasc Dis Res; 2022; 19(4):14791641221113788. PubMed ID: 35861372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.